Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilbert Zwart

Showing results (11-20 of 178) with videos related to

Pageof 18
Sort By:
Nature Reviews. Clinical Oncology|July 25, 2012
Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy?Karin Beelen, Wilbert Zwart, Sabine C Linn
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|February 10, 2011
Estrogen receptor-positive breast cancer: a multidisciplinary challengeWilbert Zwart, Vasiliki Theodorou, Jason S Carroll
Molecular Aspects of Medicine|December 28, 2020
Estrogen Receptor on the move: Cistromic plasticity and its implications in breast cancerIsabel Mayayo-Peralta, Stefan Prekovic, Wilbert Zwart
Endocrinology|September 20, 2022
Homing in on a Moving Target: Androgen Receptor Cistromic Plasticity in Prostate CancerNils Eickhoff, Andries M Bergman, Wilbert Zwart
Endocrine-Related Cancer|April 14, 2021
Duality of glucocorticoid action in cancer: tumor-suppressor or oncogene?Isabel Mayayo-Peralta, Wilbert Zwart, Stefan Prekovic
Trends in Molecular Medicine|February 11, 2025
The emerging regulatory interface between DNA repair and steroid hormone receptors in cancerBim de Klein, Nils Eickhoff, Wilbert Zwart
Life Science Alliance|November 21, 2018
ERα activity depends on interaction and target site corecruitment with phosphorylated CREB1Melissa Berto, Valerie Jean, Wilbert Zwart, et al.
Nuclear Receptor Signaling|April 28, 2007
Visualizing the action of steroid hormone receptors in living cellsAlexander Griekspoor, Wilbert Zwart, Jacques Neefjes, et al.
European Journal of Pharmacology|April 3, 2013
Tamoxifen resistance: from bench to bedsideMarjolein Droog, Karin Beelen, Sabine Linn, et al.
The Lancet. Oncology|November 28, 2012
ChIPing away at breast cancerLuca Magnani, Jason Carroll, Wilbert Zwart, et al.
Pageof 18

Showing results (11-20 of 178) with videos related to

Sort By:
Pageof 18
Nature Reviews. Clinical Oncology|July 25, 2012
Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy?Karin Beelen, Wilbert Zwart, Sabine C Linn
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|February 10, 2011
Estrogen receptor-positive breast cancer: a multidisciplinary challengeWilbert Zwart, Vasiliki Theodorou, Jason S Carroll
Molecular Aspects of Medicine|December 28, 2020
Estrogen Receptor on the move: Cistromic plasticity and its implications in breast cancerIsabel Mayayo-Peralta, Stefan Prekovic, Wilbert Zwart
Endocrinology|September 20, 2022
Homing in on a Moving Target: Androgen Receptor Cistromic Plasticity in Prostate CancerNils Eickhoff, Andries M Bergman, Wilbert Zwart
Endocrine-Related Cancer|April 14, 2021
Duality of glucocorticoid action in cancer: tumor-suppressor or oncogene?Isabel Mayayo-Peralta, Wilbert Zwart, Stefan Prekovic
Trends in Molecular Medicine|February 11, 2025
The emerging regulatory interface between DNA repair and steroid hormone receptors in cancerBim de Klein, Nils Eickhoff, Wilbert Zwart
Life Science Alliance|November 21, 2018
ERα activity depends on interaction and target site corecruitment with phosphorylated CREB1Melissa Berto, Valerie Jean, Wilbert Zwart, et al.
Nuclear Receptor Signaling|April 28, 2007
Visualizing the action of steroid hormone receptors in living cellsAlexander Griekspoor, Wilbert Zwart, Jacques Neefjes, et al.
European Journal of Pharmacology|April 3, 2013
Tamoxifen resistance: from bench to bedsideMarjolein Droog, Karin Beelen, Sabine Linn, et al.
The Lancet. Oncology|November 28, 2012
ChIPing away at breast cancerLuca Magnani, Jason Carroll, Wilbert Zwart, et al.
Pageof 18